Comment
doi: 10.1016/j.jhep.2023.04.009.
Epub 2023 Apr 20.
Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations
Affiliations
- PMID: 37086922
- DOI: 10.1016/j.jhep.2023.04.009
Item in Clipboard
Comment
Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations
J Hepatol.
2023 Sep.
Free article
No abstract available
Comment in
-
Reply to: "Improved basic performance of iTACT-HBcrAg assay" and "Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations".J Hepatol. 2023 Sep;79(3):e136-e137. doi: 10.1016/j.jhep.2023.05.047. Epub 2023 Jun 29. J Hepatol. 2023. PMID: 37392839 No abstract available.
Comment on
-
A critique and systematic review of the clinical utility of hepatitis B core-related antigen.J Hepatol. 2023 Apr;78(4):731-741. doi: 10.1016/j.jhep.2022.12.017. Epub 2022 Dec 28. J Hepatol. 2023. PMID: 36586590
Publication types
LinkOut - more resources
Full Text Sources
